Related Experiment Video
Updated: Sep 3, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
An approach to acute clinical deterioration in patients with late-stage Parkinson's disease
Laura Williams1, Jessica Qiu2, Sophie Waller3
1MB BCh BAO, MRCPI, MD, Movement Disorder Fellow, Movement Disorder Unit, Department of Neurology, Westmead Hospital, Westmead, NSW.
Background:
Idiopathic Parkinson's disease is a slowly progressive neurodegenerative disease. In the absence of disease-modifying therapies, patients inevitably progress to late-stage disease, characterised by a shift towards increasing disability from predominantly non-motor symptoms, which may be poorly levodopa responsive.
Objective:
The aim of this article is to provide general practitioners (GPs) with a practical approach to the diagnosis and management of acute clinical deterioration in patients with late-stage Parkinson's disease. The authors outline common causes for such change and an approach to their workup and management.
Discussion:
With an ageing population, we are seeing an increased prevalence of Parkinson's disease at all stages. Neurologists, geriatricians and GPs alike should therefore be familiar with the syndrome of late-stage Parkinson's disease and be equipped with treatment strategies to address acute non-motor and motor deteriorations.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Psychosis: Goals of Pharmacotherapy
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drug Therapy
Antianxiety Medications
Heart Failure V: Medical Management

